“Risk Factors” Check Up Package - For Women | 4DCenter Warsaw, Poland

• Consultation of internist
• Consultation of radiologist
• Consultation of dermatologist
• Consultation of gynecologist
• Consultation of endoscopist
• Consultation of anesthesiologist

• Comprehensive blood test (extended): blood morphology, ALT, AST, total bilirubin, direct and indirect bilirubin, alkaline phosphatase, GGTP (GGT, gamma- glutamyltranspeptidase), total protein, creatinine, urea, sodium, potassium, chloride, calcium, C-reactive protein, glucose, magnesium, international normalized ratio (INR)
• Blood type and immune alloantibodies, APTT (kaolin-cephalin time), glutathione, and reduced/oxidized glutathione ratio
• Serum iron, ferritin, transferrin
• TSH, FT3, FT4
• BRCA1, BRCA2 markers (tumor markers of ovarian cancer), CA 72-4 (gastrointestinal cancer marker), CA 19-9 (pancreas cancer antigens), CEA (carcinoembryonic antigen), oncomarker Cyfra 21-1, alpha-fetoprotein, SCC antigen (squamous cell carcinoma antigen), beta2-microglobulin, NSE (neurospecific enolase), CA 15-3 (breast cancer marker antigen), HE4 cancer marker
• Occult blood test
• Helicobacter pylori, IgM
• Liquid-based cytology (LBC) + HPV test

• Cost of essential materials
• Nursing service
• Discharge medical records
• Further recommendations
• Accommodation is not included, it is possible for an additional price

The “Risk Factors” check-up package for women at 4DCenter Warsaw, Poland, offers an extensive evaluation to detect various health issues early. This package includes consultations with specialists in internal medicine, radiology, dermatology, gynecology, endoscopy, and anesthesiology. Comprehensive blood tests analyze a wide range of markers, including liver enzymes (ALT, AST), bilirubin levels, kidney function markers (creatinine, urea), and electrolytes (sodium, potassium, chloride). It also includes an extended cancer marker panel to screen for multiple types of cancers. Imaging studies such as abdominal ultrasound, elastography, and ultrasounds of the kidneys, thyroid, and breasts are performed alongside functional tests like ECG, pulse oximetry, and spirometry. Endoscopy procedures, including gastroscopy and colonoscopy, with optional polypectomy, are conducted under general anesthesia to ensure thorough gastrointestinal tract examination.

This package also features advanced diagnostics like liquid-based cytology (LBC) with HPV testing, transvaginal ultrasound, and dermatoscopy for skin cancer screening. These tests collectively aid in diagnosing various conditions, from gastrointestinal, liver, and thyroid disorders to cancers of the lungs, prostate, cervix, and skin. Regular monitoring and early detection through this comprehensive check-up can significantly improve treatment outcomes and overall health management. The package also provides nursing services, discharge medical records, and personalized recommendations based on the findings.

The package includes specific cancer markers that enhance the diagnostic capabilities. BRCA1 and BRCA2 markers are crucial for identifying genetic predispositions to ovarian and breast cancers. CA 72-4 is used to detect gastrointestinal cancers, while CA 19-9 is specific for pancreatic cancers. CEA (carcinoembryonic antigen) is a marker for colorectal and other cancers. Cyfra 21-1 is associated with lung cancer, and alpha-fetoprotein can indicate liver cancer. SCC antigen helps diagnose squamous cell carcinomas, beta2-microglobulin is used for multiple myeloma and lymphomas, and NSE (neurospecific enolase) is significant for neuroendocrine tumors. CA 15-3 is a marker for breast cancer, and the HE4 cancer marker is particularly useful in ovarian cancer detection. These markers are instrumental in the early detection and monitoring of various cancers, providing vital information for timely and effective treatment.